FDAFDA · Food and drugs·Recall number D-0112-2021
ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30
Published December 9, 2020 · Recall initiated: November 17, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot #: GS026353, GS027150, GS027653, GS028044, Exp. Date: 02/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.